LIP
CLRB icon

Lighthouse Investment Partners’s Cellectar Biosciences CLRB Stock Holding History

Lighthouse Investment Partners’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,625
Closed -$552K – 419
2024
Q1 		$552K Buy
+4,625
New +$501K 0.03% 323

Other funds holding CLRB

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lighthouse Investment Partners's CLRB Position: Q2 2024 in Review

Lighthouse Investment Partners sold out of Cellectar Biosciences (CLRB) in Q2 2024, closing a stake of 4,625 shares — an estimated $552K sold.

Lighthouse Investment Partners first reported a position in CLRB in Q1 2024 and held it in 1 quarter. The position peaked at $552K in Q1 2024. 37 funds tracked by Wall St. Rank hold CLRB as of Q2 2024.

  • Lighthouse Investment Partners reported no remaining Cellectar Biosciences position as of Q2 2024 after selling out during the quarter.
  • Lighthouse Investment Partners sold 4,625 Cellectar Biosciences shares in Q2 2024, an estimated $552K.
  • Lighthouse Investment Partners first reported a position in Cellectar Biosciences in Q1 2024 and held it in 1 quarter.
  • Lighthouse Investment Partners's Cellectar Biosciences position peaked at $552K in Q1 2024.
  • 37 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q2 2024.

Based on Lighthouse Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.